本文選題：缺氧 + 去鐵胺��； 參考：《暨南大學(xué)》2011年碩士論文

【摘要】：目的：間充質(zhì)干細(xì)胞(Mesenchymal stem cells, MSCs)在治療缺血缺氧性疾病時(shí),其治療效能的發(fā)揮與損傷組織中的缺氧環(huán)境密切相關(guān)。本文旨在探索缺氧對(duì)人臍帶MSCs的形態(tài)、超微結(jié)構(gòu)、增殖及蛋白差異表達(dá)的影響,篩選MSCs治療缺血缺氧性疾病的新靶點(diǎn),進(jìn)而嘗試探索MSCs的進(jìn)一步臨床應(yīng)用。 方法：(1)膠原酶消化法聯(lián)合貼壁法從人臍帶組織中分離提取MSCs,油紅O染色鑒定細(xì)胞成脂分化能力,Von Kossa法鑒定細(xì)胞成骨分化能力。(2)流式細(xì)胞儀測(cè)正常人臍帶MSCs的免疫表型及細(xì)胞周期比例。(3)缺氧模擬劑去鐵胺(Deferoxamine, DFO)及氯化鈷(Cobalt chloride, CoCl2)分別處理人臍帶MSCs,原子力顯微鏡(AFM)及透射電鏡(TEM)觀察DFO及CoCl2對(duì)人臍帶MSCs形態(tài)及超微結(jié)構(gòu)變化。(4)MTT法測(cè)DFO及CoCl2對(duì)人臍帶MSCs增殖的影響。(5)流式細(xì)胞儀測(cè)DFO及CoCl2對(duì)人臍帶MSCs細(xì)胞周期的影響。(6)雙向凝膠電泳技術(shù)(2-DE)分離CoCl2作用前后的人臍帶MSCs總蛋白,ImageMaster 2D Platinum軟件分析蛋白質(zhì)差異表達(dá)點(diǎn),基質(zhì)輔助激光解析串聯(lián)飛行時(shí)間質(zhì)譜對(duì)差異表達(dá)的蛋白進(jìn)行鑒定及功能分類。 結(jié)果：(1)人臍帶MSCs的G0/G1期細(xì)胞占89.4%,高表達(dá)CD29, CD44, CD 105,低表達(dá)或不表達(dá)CD106, CD40, CD34, CD45, HLA-DR。(2)人臍帶MSCs向脂肪細(xì)胞誘導(dǎo)分化,油紅O染色后可見脂滴呈紅色。人臍帶MSCs向成骨細(xì)胞誘導(dǎo)分化,Von Kossa染色可見黑色礦化結(jié)節(jié)沉積。(3)DFO及CoCl2處理人臍帶MSCs后,細(xì)胞變長(zhǎng),毗鄰的細(xì)胞間網(wǎng)狀結(jié)構(gòu)消失,代之以間隙。細(xì)胞內(nèi)出現(xiàn)大量空泡狀結(jié)構(gòu),粗面內(nèi)質(zhì)網(wǎng)擴(kuò)張成池,線粒體嵴擴(kuò)張。(4)DFO及CoCl2明顯抑制人臍帶MSCs增殖,隨DFO及CoCl2濃度增加,增殖抑制率遞增,120μmol/lDFO組,10μmol/lCoCl2組及100μmol/lCoCl2組與對(duì)照組相比差異有統(tǒng)計(jì)學(xué)意義(P0.05)。(5)DFO及CoCl2使人臍帶MSCs的G0/G1期細(xì)胞比例增加,G2/M/S期細(xì)胞比例減少。(6)建立了CoCl2作用人臍帶MSCs的蛋白差異表達(dá)譜,鑒定出26個(gè)差異表達(dá)蛋白,其中11個(gè)表達(dá)上調(diào),15個(gè)表達(dá)下調(diào)。 結(jié)論：(1)缺氧模擬劑DFO及CoCl2使人臍帶MSCs形態(tài)及超微結(jié)構(gòu)發(fā)生改變,并通過影響細(xì)胞周期而抑制MSCs增殖。(2)CoCl2對(duì)人臍帶MSCs蛋白差異表達(dá)的影響涉及多蛋白通路,包括糖代謝、核酸代謝、脂類代謝、蛋白質(zhì)代謝和修飾；輔酶與輔基代謝；細(xì)胞周期；免疫和防御；細(xì)胞結(jié)構(gòu)和運(yùn)動(dòng)；信號(hào)轉(zhuǎn)導(dǎo)；蛋白靶向和定位；胞內(nèi)蛋白運(yùn)輸；神經(jīng)細(xì)胞的活動(dòng)；肌肉收縮等多種生物學(xué)功能。
[Abstract]:Aim: the efficacy of mesenchymal stem cells, MSCs) in the treatment of ischemic hypoxic diseases is closely related to the hypoxic environment in injured tissues. The purpose of this study was to explore the effects of hypoxia on the morphology, ultrastructure, proliferation and differential expression of protein in human umbilical cord MSCs, to screen new targets for the treatment of ischemic and hypoxic diseases with MSCs, and to explore the further clinical application of MSCs. Methods MSCs were isolated and extracted from human umbilical cord tissues by collagenase digestion and adherent method. The ability of adipogenic differentiation was evaluated by oil red O staining and the osteogenic differentiation ability was evaluated by Von Kossa) flow cytometry (FCM) was used to detect the immunity of normal human umbilical cord MSCs. Morphologic and ultrastructural changes of human umbilical cord MSCs treated with deferoxamine (DFOO) and Cobalt chloride (CoCl2) were observed by DFO and CoCl2 under transmission electron microscope (TEM) and atomic force microscope (AFM) respectively. Effects of DFO and CoCl2 on the Proliferation of Human umbilical Cord MSCs. (5) flow cytometry was used to detect the effect of DFO and CoCl2 on the cell cycle of human umbilical MSCs. Two-dimensional gel electrophoresis (2-DEE) was used to isolate the differential expression points of human umbilical cord MSCs total protein imageMaster 2D Platinum before and after CoCl2 treatment. Matrix assisted laser desorption tandem time of flight mass spectrometry was used to identify and classify differentially expressed proteins. Results the percentage of G0/G1 phase cells in human umbilical cord MSCs was 89.4.The high expression of CD29, CD44, CD105, low expression or non-expression of CD106, CD40, CD34, CD45, HLA-DR. 2) induced differentiation of human umbilical cord MSCs into adipocytes, and lipid droplets were red after oil red O staining. The differentiation of human umbilical cord MSCs into osteoblast induced by Von Kossa staining showed that the cells became longer and the adjacent intercellular reticular structure disappeared and the space was replaced by the black mineralized nodular deposition. After treated with CoCl2, the cells became longer and the adjacent intercellular reticular structure disappeared. A large number of vacuolated structures appeared in the cells, the rough endoplasmic reticulum expanded into a pool, and the mitochondrial cristal dilatation. DFO and CoCl2 significantly inhibited the proliferation of MSCs in human umbilical cord, which increased with the concentration of DFO and CoCl2. There were significant differences in proliferation inhibition rate between 10 渭 mol/lCoCl2 group and 100 渭 mol/lCoCl2 group compared with the control group. Compared with the control group, the increase of G0/G1 phase cell proportion of MSCs in human umbilical cord and the increase of G0/G1 phase cell proportion of MSCs in human umbilical cord by CoCl2. The protein differential expression profile of MSCs in human umbilical cord induced by CoCl2 was established. 26 differentially expressed proteins were identified, of which 11 were up-regulated and 15 down-regulated. Conclusion the anoxic analogue DFO and CoCl2 can change the morphology and ultrastructure of MSCs in human umbilical cord, and inhibit the proliferation of MSCs by affecting the cell cycle. The effect of CoCl2 on the differential expression of MSCs protein in human umbilical cord involves many protein pathways, including glucose metabolism and nucleic acid metabolism. Keywords lipid metabolism, protein metabolism and modification; coenzyme and coenzyme metabolism; cell cycle; immunity and defense; cell structure and movement; signal transduction; protein targeting and localization; intracellular protein transport; neuronal activity; Muscle contraction and other biological functions.
【學(xué)位授予單位】：暨南大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2011
【分類號(hào)】：R329

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 黃凌瑾;陳勝喜;羅萬俊;蔣海河;張鵬飛;易紅;;非小細(xì)胞肺癌分泌蛋白的蛋白質(zhì)組學(xué)研究(英文)[J];癌癥;2006年11期

2 沈馳斌;盧德趙;沃興德;李曉娟;江婷婷;王科;;RAW264.7細(xì)胞泡沫化前后差異蛋白質(zhì)組分析[J];中國(guó)動(dòng)脈硬化雜志;2009年03期

3 任今鵬,蔣雨平;囊泡單胺轉(zhuǎn)運(yùn)體的研究進(jìn)展[J];中國(guó)臨床神經(jīng)科學(xué);2004年01期

4 吳鳴;金松華;沈定;張佩華;石桂枝;;兒童病毒性腦炎腦脊液腫瘤壞死因子和神經(jīng)元特異性烯醇化酶的變化[J];實(shí)用中西醫(yī)結(jié)合臨床;2007年01期

5 張一甫;秦兆宇;劉曉慧;林成招;賀福初;;應(yīng)用8標(biāo)iTRAQ技術(shù)結(jié)合2D LC-MS/MS分析大鼠再生肝的差異蛋白質(zhì)組[J];分析測(cè)試學(xué)報(bào);2010年05期

6 鐘啟;曾慧蘭;;低氧對(duì)間充質(zhì)干細(xì)胞生物學(xué)特性的影響[J];中國(guó)組織工程研究與臨床康復(fù);2009年40期

7 何覓春;李靜;趙春華;;低氧對(duì)間充質(zhì)干細(xì)胞的影響[J];中國(guó)實(shí)驗(yàn)血液學(xué)雜志;2007年02期

8 呂璐璐;宋永平;魏旭東;房伯俊;張艷莉;李玉富;;人臍帶和骨髓源間充質(zhì)干細(xì)胞生物學(xué)特征的對(duì)比研究[J];中國(guó)實(shí)驗(yàn)血液學(xué)雜志;2008年01期

9 張一瓊;李薇;王冠軍;楊巖;王杰;張學(xué)敏;;應(yīng)用蛋白質(zhì)組學(xué)方法研究低劑量輻射對(duì)人骨髓間充質(zhì)干細(xì)胞的影響[J];中國(guó)實(shí)驗(yàn)血液學(xué)雜志;2008年01期

10 侯瑞琴;王婧;孔圓;陳育紅;黃曉軍;曾洋;葛健;劉全華;趙春華;劉開彥;;單倍體相合造血干細(xì)胞移植聯(lián)合間充質(zhì)干細(xì)胞輸注對(duì)患者造血微環(huán)境的影響[J];中國(guó)實(shí)驗(yàn)血液學(xué)雜志;2010年01期

，

本文編號(hào)：1931668